#USA #New York #Class Action #Wolf Haldenstein #Picard Medical

Investors Urged to Join Class Action Lawsuit Against Picard Medical, Inc.

In a significant development for investors, Wolf Haldenstein Adler Freeman & Herz LLP has announced the filing of a class action lawsuit on behalf of individuals and entities who acquired shares in Picard Medical, Inc. (NYSE: PMI) during a specified period of fraud and misinformation. This lawsuit is particularly relevant for those who purchased shares between September 2, 2025 and October 31, 2025.

Allegations of Fraudulent Activities

The central allegations of the complaint include serious misrepresentations made by the company and its executives. It is claimed that the defendants disseminated false and misleading statements about the company's financial health, thus creating a facade that ultimately harmed investors. Additionally, there were failures to disclose critical information regarding the fraudulent stock promotion schemes that involved social media manipulation and impersonations of financial experts. The lawsuit highlights the following key points:

• - Misrepresentation: The defendants purportedly misled investors by not addressing the material adverse facts surrounding the company, which played a significant role in influencing the stock price.
• - Insider Trading: Reports suggest that company insiders or associates might have used offshore accounts to unload shares during an artificially inflationary period, raising ethical concerns about their practices and accountability.
• - Abandonment of Duty: The public statements made during this time are alleged to have omitted crucial information about the misleading rumors that fueled the stock’s volatility.

Important Dates and Next Steps for Investors

Investors seeking to be recognized as lead plaintiffs in this class action lawsuit must act swiftly. The deadline for filing a motion is April 3, 2026. Affected shareholders are therefore encouraged to come forward to secure their standing and potentially reclaim losses incurred due to the alleged wrongdoing.

Wolf Haldenstein is pursuing justice, leveraging over 125 years of expertise in securities litigation. Their objective is clear: to protect the interests of investors who have faced financial setbacks due to the malfeasance of corporate entities. The firm invites all affected parties to participate in this legal action to foster accountability and restore investor confidence.

How to Get Involved

Those who believe they are affected can reach out directly to the Wolf Haldenstein legal team. Specifically, individuals are encouraged to contact:

• - Phone: (800) 575-0735 or (212) 545-4774
• - Email: [email protected]
• - Contact Person: Gregory Stone, Director of Case and Financial Analysis

For additional details regarding this case and to stay updated, interested parties can visit the Wolf Haldenstein website, which serves as a resource for investors looking to understand their rights and seek appropriate legal recourse.

This announcement serves as a reminder of the ongoing risks and responsibilities tied to investment, as well as the critical role of transparency and truth in the financial market. As the lawsuit unfolds, it will serve as a benchmark for corporate accountability and investor protection in an increasingly complex financial environment.

Conclusion

As the landscape of securities litigation evolves, this case against Picard Medical is emblematic of the need for vigilant investor rights protection. If you have been affected by this misrepresentation, don’t hesitate to reach out to law professionals who can provide guidance through this process. Investors have the power to influence change and demand accountability from corporations through collective action.